1-3 of 3
Pablo Peña-Martínez
Close
Sort by
Journal Articles

Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity

Maria Rodriguez-Zabala, Ramprasad Ramakrishnan, Katrin Reinbach, Somadri Ghosh, Leal Oburoglu, Antoni Falqués-Costa, Kishan Bellamkonda, Mats Ehinger, Pablo Peña-Martínez, Noelia Puente-Moncada, Henrik Lilljebjörn, Jörg Cammenga, Cornelis Jan Pronk, Vladimir Lazarevic, Thoas Fioretos, Anna K. Hagström-Andersson, Niels-Bjarne Woods, Marcus Järås
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5382–5395.
https://doi.org/10.1182/bloodadvances.2023009967
Published: 2023
Includes: Supplemental data
Journal Articles

The complement receptor C3AR constitutes a novel therapeutic target in NPM1 -mutated AML

Sofia von Palffy, Hanna Thorsson, Pablo Peña-Martínez, Noelia Puente-Moncada, Carl Sandén, Anna M. Blom, Rasmus Henningsson, Gunnar Juliusson, Ben King, Niklas Landberg, Vladimir Lazarevic, Christina Orsmark-Pietras, Marianne Rissler, Vendela Rissler, Helena Ågerstam, Marcus Järås, Henrik Lilljebjörn, Thoas Fioretos
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1204–1218.
https://doi.org/10.1182/bloodadvances.2022007682
Published: 2023
Includes: Supplemental data
Journal Articles

Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells

Mia Eriksson, Pablo Peña-Martínez, Ramprasad Ramakrishnan, Marion Chapellier, Carl Högberg, Gabriella Glowacki, Christina Orsmark-Pietras, Talía Velasco-Hernández, Vladimir Lj Lazarević, Gunnar Juliusson, Jörg Cammenga, James C. Mulloy, Johan Richter, Thoas Fioretos, Benjamin L. Ebert, Marcus Järås
Journal: Blood Advances
Blood Adv (2017) 1 (23): 2046–2057.
https://doi.org/10.1182/bloodadvances.2017006148
Published: 2017
Includes: Supplemental data